Drug Shortage Report for CALMYLIN PSE WITH CODEINE

Last updated on 2019-08-16 History
Report ID 87659
Drug Identification Number 02172917
Brand name CALMYLIN PSE WITH CODEINE
Common or Proper name CALMYLIN CODEINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PSEUDOEPHEDRINE HYDROCHLORIDE CODEINE PHOSPHATE GUAIFENESIN
Strength(s) 30MG 3.3MG 100MG
Dosage form(s) SOLUTION
Route of administration ORAL
Packaging size 100ML
ATC code R05FA
ATC description COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-27
Estimated end date 2019-08-30
Actual end date 2019-08-15
Shortage status Resolved
Updated date 2019-08-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-08-16 English Compare
v7 2019-08-15 French Compare
v6 2019-08-15 English Compare
v5 2019-08-06 French Compare
v4 2019-08-06 English Compare
v3 2019-06-28 English Compare
v2 2019-06-27 French Compare
v1 2019-06-27 English Compare

Showing 1 to 8 of 8